Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (9970)	10/30/1998 10:17:00 AM
From: MoneyMade	Read Replies (1) \| Respond to of 29382

3 for 1 stock split anyone??? today's the last chance (Inside) Southside sets stock split, ups dividend ST. LOUIS, Oct 2 (Reuters) - Southside Bancshares Corp. said Friday its board of directors has approved a three-for-one stock split payable in the form of a stock dividend. The company said it has also set a post-split quarterly dividend of $0.08 a share, an effective increase of nine percent. Southside previously paid a dividend of $0.22. The additional shares will be distributed November 15 to shareholders of record November 2. The quarterly dividend will be payable December 15 to shareholders of record December 8. -------------------------------------------------------------------------------- More Quotes and News: Southside Bancshares Corp (Nasdaq:SBCO - ne M$neyMade

To: Ditchdigger who wrote (9970)	10/30/1998 11:20:00 AM
From: Ken W	Respond to of 29382

DD, Just two words....GYMB and YYYYYYYYEEEEEEEEEHHHHHHHHAAAAAAA! Ken

To: Ditchdigger who wrote (9970)	10/30/1998 10:56:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 29382

BTGC, nice find. Profitable bio-tech is rare, and this one has some potential kickers to boot. The PE is low when you look at their growth rate. Did you see the profit margin !!!!!!!! Their deal with Sumitomo to sell Bio-Tropin in Japan will boost sales for their leading product and are about to receive royalties for use of their technology in the Merced contraceptive, they are set to begin selling BioLon, an opthamlic product in Nov. The stock could get a big boost if and when they obtain approval in Israel for their hepatitis B shot. This approval could come any day now. Did you look at the warrants ? Convertible at 7, I think and expire soon. The short interest on the stock is quite large and earnings are due next week. Promises to be very interesting. Did you see this article? : jpost.com